Acne Treatment Market Expected To Hit USD 14.44 Billion By 2032 With A Remarkable 4.6% CAGR
Analysis of acne treatment market across medication types & therapeutic devices; regional growth patterns & end-user insights through 2032 ...
The Pharma Letter23h
Samsung Bioepis and Teva link up on Soliris biosimilar in USA
South Korean biosimilars developer Samsung Bioepis and Israel’s Teva Pharmaceutical Industries have entered into a license, ...